Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
by
Patel, Nileshkumar J.
, Badheka, Apurva O.
, Mehta, Jawahar L.
, Mehta, Kathan
, Rathod, Ankit
, Shah, Neeraj
, Singh, Vikas
, Arora, Shilpkumar
, Grover, Peeyush M.
, Patel, Nilay
, Deshmukh, Abhishek J.
, Mitrani, Raul D.
, Marzouka, George R.
, Savani, Ghanshyambhai T.
, Chothani, Ankit
, Lafferty, James
in
Aged
/ Anti-Arrhythmia Agents - therapeutic use
/ Atrial Fibrillation - drug therapy
/ Atrial Fibrillation - physiopathology
/ Blood Pressure - drug effects
/ Blood Pressure - physiology
/ Blood Pressure Determination
/ Cardiac arrhythmia
/ Cardiovascular
/ Drug therapy
/ Female
/ Follow-Up Studies
/ Heart attacks
/ Heart Rate - drug effects
/ Heart Rate - physiology
/ Humans
/ Male
/ Mortality
/ Older people
/ Retrospective Studies
/ Time Factors
/ Treatment Outcome
2014
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
by
Patel, Nileshkumar J.
, Badheka, Apurva O.
, Mehta, Jawahar L.
, Mehta, Kathan
, Rathod, Ankit
, Shah, Neeraj
, Singh, Vikas
, Arora, Shilpkumar
, Grover, Peeyush M.
, Patel, Nilay
, Deshmukh, Abhishek J.
, Mitrani, Raul D.
, Marzouka, George R.
, Savani, Ghanshyambhai T.
, Chothani, Ankit
, Lafferty, James
in
Aged
/ Anti-Arrhythmia Agents - therapeutic use
/ Atrial Fibrillation - drug therapy
/ Atrial Fibrillation - physiopathology
/ Blood Pressure - drug effects
/ Blood Pressure - physiology
/ Blood Pressure Determination
/ Cardiac arrhythmia
/ Cardiovascular
/ Drug therapy
/ Female
/ Follow-Up Studies
/ Heart attacks
/ Heart Rate - drug effects
/ Heart Rate - physiology
/ Humans
/ Male
/ Mortality
/ Older people
/ Retrospective Studies
/ Time Factors
/ Treatment Outcome
2014
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
by
Patel, Nileshkumar J.
, Badheka, Apurva O.
, Mehta, Jawahar L.
, Mehta, Kathan
, Rathod, Ankit
, Shah, Neeraj
, Singh, Vikas
, Arora, Shilpkumar
, Grover, Peeyush M.
, Patel, Nilay
, Deshmukh, Abhishek J.
, Mitrani, Raul D.
, Marzouka, George R.
, Savani, Ghanshyambhai T.
, Chothani, Ankit
, Lafferty, James
in
Aged
/ Anti-Arrhythmia Agents - therapeutic use
/ Atrial Fibrillation - drug therapy
/ Atrial Fibrillation - physiopathology
/ Blood Pressure - drug effects
/ Blood Pressure - physiology
/ Blood Pressure Determination
/ Cardiac arrhythmia
/ Cardiovascular
/ Drug therapy
/ Female
/ Follow-Up Studies
/ Heart attacks
/ Heart Rate - drug effects
/ Heart Rate - physiology
/ Humans
/ Male
/ Mortality
/ Older people
/ Retrospective Studies
/ Time Factors
/ Treatment Outcome
2014
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
Journal Article
Optimal Blood Pressure in Patients With Atrial Fibrillation (from the AFFIRM Trial)
2014
Request Book From Autostore
and Choose the Collection Method
Overview
Many medications used to treat atrial fibrillation (AF) also reduce blood pressure (BP). The relation between BP and mortality is unclear in patients with AF. We performed a post hoc analysis of 3,947 participants from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management trial. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) at baseline and follow-up were categorized by 10-mm Hg increments. The end points were all-cause mortality (ACM) and secondary outcome (combination of ACM, ventricular tachycardia and/or fibrillation, pulseless electrical activity, significant bradycardia, stroke, major bleeding, myocardial infarction, and pulmonary embolism). SBP and DBP followed a “U-shaped” curve with respect to primary and secondary outcomes after multivariate analysis. A nonlinear Cox proportional hazards model showed that the incidence of ACM was lowest at 140/78 mm Hg. Subgroup analyses revealed similar U-shaped curves. There was an increased ACM observed with BP <110/60 mm Hg (hazard ratio 2.4, p <0.01, respectively, for SBP and DBP). In conclusion, in patients with AF, U-shaped relation existed between BP and ACM. These data suggest that the optimal BP target in patients with AF may be greater than the general population and that pharmacologic therapy to treat AF may be associated with ACM or adverse events if BP is reduced to <110/60 mm Hg.
Publisher
Elsevier Inc,Elsevier Limited
This website uses cookies to ensure you get the best experience on our website.